To avoid unwanted side effects due to oral steroids, it is best to have a good post-cycle therapy (PCT) plan. Nolvadex ...

Clinically Inspired Gut-Skin Axis Supplement Prime Biome Faces Real Consumer Feedback and Scientific Scrutiny—Here’s What the ...

Rifai is focused on enhancing the overall lifestyle of its clients. The fun and creative packaging reinforces the idea that ...

Basis EHR established its first MVP release which subsequently made the system a preference among clinicians thus surpassing ...

More than 25 Doheny Scientists and Clinician-Scientists to Present Posters, Papers and Mini symposia at Leading Eye Research Conference ...

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills ...

BOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America is proud to announce the release of the Epilepsy & Seizure Safe Classrooms Toolkit, a comprehensive educational ...

For more information about the 2025 ATS International Conference, please visit the conference website, here. About GRI Bio, Inc.

MARKHAM, Ontario, April 16, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has finalized its previously announced acquisition of ...

Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the ...

The Company is currently advancing its plans to submit an IDE and commence U.S. clinical trials in 2025 to support a labeling indication to commercialize the Autonomix Sensing and RF Ablation System ...